Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000940180-00-000352
Filing Date
2000-03-28
Accepted
2000-03-28 00:00:00
Documents
7
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 287210
2 STRATEGIC ALLIANCE AGREEMENT EX-10.25 39727
3 AXCELL BIOSCIENCES CORPORATION STOCK OPTION PLAN EX-10.26 31443
4 MASTER LOAN AND SECURITY AGREEMENT EX-10.27 57074
5 SUBSIDIARIES OF CYTOGEN CORPORATION EX-21 354
6 CONSENT OF ARTHUR ANDERSEN LLP EX-23 2177
7 FINANCIAL DATA SCHEDULE EX-27 2375
  Complete submission text file 0000940180-00-000352.txt   422475
Mailing Address 600 COLLEGE RD EAST CN 5308 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540
Business Address 600 COLLEGE RD EAST CN 5308 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

EIN.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 581422
SIC: 2835 In Vitro & In Vivo Diagnostic Substances